参考文献/References:
[1]Christenson SA,Smith BM,Bafadhel M,et al.Chronic obstructive pulmonary disease[J].The Lancet,2022,399(10342):2227-2242.[2]Chaurasia SN,Kushwaha G,Kulkarni PP,et al.Platelet HIF-2α promotes thrombogenicity through PAI-1 synthesis and extracellular vesicle release[J].Haematologica,2019,104(12):2482-2492.[3]Shao S,Zhang Z,Feng L,et al.Association of Blood Inflammatory Biomarkers with Clinical Outcomes in Patients with AECOPD:An 8-Year Retrospective Study in Beijing[J].International Journal of Chronic Obstructive Pulmonary Disease,2023,18:1783-1802.[4]Xiong W,Xu M,Zhao Y,et al.Can we predict the prognosis of COPD with a routine blood test?[J].International Journal of Chronic Obstructive Pulmonary Disease,2017,12:615-625.[5]Forget P,Khalifa C,Defour JP,et al.What is the normal value of the neutrophil-to-lymphocyte ratio?[J].BMC Research Notes,2017,10(1):12.[6]Forget P,Teng F,Ye H,et al.Predictive value of neutrophil to lymphocyte ratio in patients with acute exacerbation of chronic obstructive pulmonary disease[J].PLoS One,2018,13(9):e0204377.[7]Liu J,Liu J,Zou Y.Relationship between neutrophil–lymphocyte ratio and short-term prognosis in the chronic obstructive pulmonary patients with acute exacerbation[J].Bioscience Reports,2019,39(5):BSR20190675.[8]Luo Z,Zhang W,Chen L,et al.Prognostic Value of Neutrophil:Lymphocyte and Platelet:Lymphocyte Ratios for 28-Day Mortality of Patients with AECOPD[J].International Journal of General Medicine,2021,14:2839-2848.[9]Gómez-Rosero JA,Cáceres-Galvis C,Ascuntar J,et al.Biomarkers as a Prognostic Factor in COPD Exacerbation:A Cohort Study[J].COPD,2021,18(3):325-332.[10]Emami Ardestani M,Alavi-Naeini N.Evaluation of the relationship of neutrophil‐to lymphocyte ratio and platelet‐to‐lymphocyte ratio with in‐hospital mortality in patients with acute exacerbation of chronic obstructive pulmonary disease[J].The Clinical Respiratory Journal,2020,15(4):382-388.[11]Yao C,Liu X,Tang Z.Prognostic role of neutrophil–lymphocyte ratio and platelet–lymphocyte ratio for hospital mortality in patients with AECOPD[J].International Journal of Chronic Obstructive Pulmonary Disease,2017,12:2285-2290.[12]Eraslan Doganay G,Cirik MO.Are Neutrophil-Lymphocyte,Platelet-Lymphocyte,and Monocyte-Lymphocyte Ratios Prognostic Indicators in Patients With Chronic Obstructive Pulmonary Disease in Intensive Care Units?[J].Cureus,2022,14(3):e23499.[13]Singh B,Kampani G,Lall B,et al.Study of Inflammatory Markers in Chronic Obstructive Pulmonary Disease[J].Journal of the Association of Physicians of India,2022,70(12):48-52.[14]Wang H,Yang T,Yu X,et al.Risk Factors for Length of Hospital Stay in Acute Exacerbation Chronic Obstructive Pulmonary Disease:A Multicenter Cross-Sectional Study[J].International Journal of General Medicine,2022,15:3447-3458.[15]Mallah H,Ball S,Sekhon J,et al.Platelets in chronic obstructive pulmonary disease:An update on pathophysiology and implications for antiplatelet therapy[J].Respiratory Medicine,2020,171:106098.[16]Lefran?觭ais E,Ortiz-Mu?觡oz G,Caudrillier A,et al.The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors[J].Nature,2017,544(7648):105-109.[17]Yao C,Wang L,Shi F,et al.Optimized combination of circulating biomarkers as predictors of prognosis in AECOPD patients complicated with Heart Failure[J].International Journal of Medical Sciences,2021,18(7):1592-1599.[18]Kumar P,Law S,Sriram KB.Evaluation of platelet lymphocyte ratio and 90-day mortality in patients with acute exacerbation of chronic obstructive pulmonary disease[J].Journal of Thoracic Disease,2017,9(6):1509-1516.[19]Liu X,Ge H,Feng X,et al.The Combination of Hemogram Indexes to Predict Exacerbation in Stable Chronic Obstructive Pulmonary Disease[J].Frontiers in Medicine,2020,7:572435.[20]Zinellu A,Paliogiannis P,Sotgiu E,et al.Platelet Count and Platelet Indices in Patients with Stable and Acute Exacerbation of Chronic Obstructive Pulmonary Disease:A Systematic Review and Meta-Analysis[J].COPD,2021,18(2):231-245.[21]Zuo H,Xie X,Peng J,et al.Predictive Value of Novel Inflammation-Based Biomarkers for Pulmonary Hypertension in the Acute Exacerbation of Chronic Obstructive Pulmonary Disease[J].Analytical Cellular Pathology,2019,2019:1-9.[22]Mirestean CC,Stan MC,Iancu RI,et al.The Prognostic Value of Platelet–Lymphocyte Ratio,Neutrophil–Lymphocyte Ratio,and Monocyte–Lymphocyte Ratio in Head and Neck Squamous Cell Carcinoma (HNSCC)—A Retrospective Single Center Study and a Literature Review[J].Diagnostics (Basel),2023,13(22):3396.[23]Vakhshoori M,Nemati S,Sabouhi S,et al.Prognostic impact of monocyte-to-lymphocyte ratio in coronary heart disease:a systematic review and meta-analysis[J].Journal of International Medical Research,2023,51(10):3000605231204469.[24]Li Q,Ma X,Shao Q,et al.Prognostic Impact of Multiple Lymphocyte-Based Inflammatory Indices in Acute Coronary Syndrome Patients[J].Frontiers in Cardiovascular Medicine,2022,9:811790.[25]Dukic V,Mur?觢ic D,Popovic Grle S,et al.Monocyte related haematological indices in acute exacerbations of COPD – a new biomarker?[J].Monaldi Archives for Chest Disease,2023,94(3).[26]Long J,Xu P,Chen J,et al.Inflammation and comorbidities of chronic obstructive pulmonary disease:The cytokines put on a mask![J].Cytokine,2023,172:156404.[27]Tong YS,Tan J,Zhou XL,et al.Systemic immune-inflammation index predicting chemoradiation resistance and poor outcome in patients with stage III non-small cell lung cancer[J].Journal of Translational Medicine,2017,15(1):221.[28]Liu B,Wang J,Li YY,et al.The association between systemic immune-inflammation index and rheumatoid arthritis:evidence from NHANES 1999–2018[J].Arthritis Research & Therapy,2023,25(1):34.[29]Sakurai K,Chubachi S,Irie H,et al.Clinical utility of blood neutrophil-lymphocyte ratio in Japanese COPD patients[J].BMC Pulmonary Medicine,2018,18(1):65.[30]Xu Y,Yan Z,Li K,et al.The association between systemic immune-inflammation index and chronic obstructive pulmonary disease in adults aged 40 years and above in the United States:a cross-sectional study based on the NHANES 2013–2020[J].Frontiers in Medicine,2023,10:1270368.[31]Benz E,Wijnant SRA,Trajanoska K,et al.Sarcopenia,systemic immune-inflammation index and all-cause mortality in middle-aged and older people with COPD and asthma:a population-based study[J].ERJ Open Research,2022,8(1):00628-2021.[32]Guang Y,Jie Z,Feng D,et al.Surrogate scale for evaluating respiratory function based on complete blood count parameters[J].Journal of Clinical Laboratory Analysis,2018,32(5):e22385.[33]Huang Y,Wang J,Shen J,et al.Relationship of Red Cell Index with the Severity of Chronic Obstructive Pulmonary Disease[J].International Journal of Chronic Obstructive Pulmonary Disease,2021,16:825-834.[34]Shi Y,Shi Y,Xu Z,et al.Association of Red Cell Index and Hospital Mortality in Chronic Obstructive Pulmonary Disease Patients Admitted to the Intensive Care Unit:A Retrospective Cohort Study[J].International Journal of Chronic Obstructive Pulmonary Disease,2023,18:2267-2276.[35]Yuan FZ,Shui W,Xing YL,et al.Association of Red Cell Index and Adverse Hospitalization Outcomes in Chronic Obstructive Pulmonary Disease Patients with Acute Exacerbation:A Retrospective Cohort Study[J]. International Journal of Chronic Obstructive Pulmonary Disease,2022,17:2263-2275.[36]El-Gazzar AG,Kamel MH,Elbahnasy OKM,et al.Prognostic value of platelet and neutrophil to lymphocyte ratio in COPD patients[J].Expert Review of Respiratory Medicine,2019,14(1):111-116.[37]Rahimirad S,Ghaffary MR,Rahimirad MH,et al.Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute exacerbation of chronic obstructive pulmonary disease[J].Tuberkuloz ve Toraks,2017,64(1):25-31.
相似文献/References:
[1]钟雪梅,李 黎,米热班·热夏提,等.α1-抗胰蛋白酶与维吾尔族慢性阻塞性肺疾病的相关性分析[J].医学信息,2018,31(02):67.[doi:10.3969/j.issn.1006-1959.2018.02.023]
ZHONG Xue-mei,LI Li,Mirban·rixat,et al.Correlation Analysis of α1-antitrypsin and Uygur Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2018,31(08):67.[doi:10.3969/j.issn.1006-1959.2018.02.023]
[2]陈文福.噻托溴铵治疗稳定期慢性阻塞性肺疾病的临床疗效分析[J].医学信息,2018,31(02):124.[doi:10.3969/j.issn.1006-1959.2018.02.045]
CHEN Wen-fu.Clinical Analysis of Tiotropium Bromide in the Treatment of Stable Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2018,31(08):124.[doi:10.3969/j.issn.1006-1959.2018.02.045]
[3]吴仲东.无创机械通气用于COPD合并呼吸衰竭的疗效分析[J].医学信息,2018,31(04):106.[doi:10.3969/j.issn.1006-1959.2018.04.036]
WU Zhong-dong.Clinical Analysis of Noninvasive Mechanical Ventilation in Patients with COPD Complicated with Respiratory Failure[J].Journal of Medical Information,2018,31(08):106.[doi:10.3969/j.issn.1006-1959.2018.04.036]
[4]龙有珠.氨茶碱联合呼吸功能训练治疗慢性阻塞性肺疾病的疗效分析[J].医学信息,2018,31(04):127.[doi:10.3969/j.issn.1006-1959.2018.04.045]
LONG You-zhu.Effect of Aminophylline Combined with Respiratory Function Training on Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2018,31(08):127.[doi:10.3969/j.issn.1006-1959.2018.04.045]
[5]皮鑫鑫,邓 革.临床药师对1例院内感染患者的病例分析[J].医学信息,2018,31(04):188.[doi:10.3969/j.issn.1006-1959.2018.04.072]
[6]罗 倩.COPD加重期患者肺功能、血气指标及
炎症指标的变化分析[J].医学信息,2018,31(09):114.[doi:10.3969/j.issn.1006-1959.2018.09.034]
LUO Qian.Changes of Pulmonary Function,Blood Gas and Inflammation in Patients with COPD Exacerbation[J].Journal of Medical Information,2018,31(08):114.[doi:10.3969/j.issn.1006-1959.2018.09.034]
[7]赵志国.有创-无创序贯通气疗法治疗慢性阻塞性肺疾病
引发的严重呼吸衰竭的临床研究[J].医学信息,2018,31(11):110.[doi:10.3969/j.issn.1006-1959.2018.11.034]
ZHAO Zhi-guo.Clinical Study of Invasive Non-invasive Sequential Ventilation in Treatment of Severe Respiratory Failure Caused by Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2018,31(08):110.[doi:10.3969/j.issn.1006-1959.2018.11.034]
[8]金彦青.NPPV治疗慢性阻塞性肺疾病合并
重症呼吸衰竭的临床疗效观察[J].医学信息,2018,31(14):113.[doi:10.3969/j.issn.1006-1959.2018.14.033]
JIN Yan-qing.Clinical Efficacy of NPPV in the Treatment of Chronic Obstructive Pulmonary Disease with Severe Respiratory Failure[J].Journal of Medical Information,2018,31(08):113.[doi:10.3969/j.issn.1006-1959.2018.14.033]
[9]张 林,白 俐.扶正化瘀胶囊对慢性阻塞性肺疾病患者炎性因子及
MMP-9、TIMP-1的影响[J].医学信息,2018,31(14):152.[doi:10.3969/j.issn.1006-1959.2018.14.047]
ZHANG Lin,BAI Li.Effect of Fuzheng Huayu Capsule on Inflammatory Factors,MMP-9 and TIMP-1 in Patients with Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2018,31(08):152.[doi:10.3969/j.issn.1006-1959.2018.14.047]
[10]张善芳,汤 杰.穴位注射联合沙美特罗替卡松粉吸入剂治疗
慢性阻塞性肺疾病稳定期的临床疗效观察[J].医学信息,2018,31(16):131.[doi:10.3969/j.issn.1006-1959.2018.16.041]
ZHANG Shan-fang,TANG Jie.Clinical Observation of Acupoint Injection Combined with Salmeterol and Fluticasone Powder Inhalation in the Treatment of Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2018,31(08):131.[doi:10.3969/j.issn.1006-1959.2018.16.041]